Anthony Harries

Family Health International, Malawi Country Office, Malawi

Dr. Harris is an infectious disease physician and epidemiologist whose research interests include emerging pathogens, antimicrobial-resistant bacteria, infection control interventions, epidemiologic methods in infectious diseases and medical informatics. He has published over 45 papers and has funding from the National Institute of Health to study antibiotic resistance.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Public Health & Epidemiology > Epidemiology (since 10 November 2005)

All recent recommendations

• 4.9
  Severe anemia in Malawian children.
  Recommended by Anthony Harries, Arjen Dondorp, Asok Antony
  
• 3.5
  HLA-B*5701 screening for hypersensitivity to abacavir.
  Recommended by Anthony Harries, Kathryn Phillips, Lindy Fox, Nikhil Yawalkar, Kiat Ruxrungtham
  
• 8.5
  Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa.
  Recommended by Hans-Walter Pfister with Uwe Koedel, Phillip Peterson, Patrick Ray, Anthony Harries, Charles Newton with Samson Gwer
  
• 3.0
  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.
  Recommended by Anthony Harries
  
• 3.0
  Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study.
  Recommended by Anthony Harries
  
• 3.0
  Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe.
  Recommended by Anthony Harries
  
• 3.0
  Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.
  Recommended by Anthony Harries
  
• 3.0
  Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.
  Recommended by Anthony Harries
  
• 3.0
  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
  Recommended by Anthony Harries
  
• 3.0
  Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.
  Recommended by Anthony Harries
  
• 6.0
  Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
  Recommended by Anthony Harries
  
• 3.0
  Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial.
  Recommended by Anthony Harries
  
• 8.0
  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
  Recommended by Anthony Harries, Linda Baum
  
• 6.0
  Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
  Recommended by Anthony Harries
  
• 6.0
  Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
  Recommended by Anthony Harries
  
• 3.0
  Return of chloroquine antimalarial efficacy in Malawi.
  Recommended by Anthony Harries
  
• 4.8
  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
  Recommended by Anthony Harries, Paul Volberding
  
• 3.0
  Microscopic-observation drug-susceptibility assay for the diagnosis of TB.
  Recommended by Anthony Harries
  
• 3.0
  Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
  Recommended by Anthony Harries
  
• 3.0
  HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
  Recommended by Anthony Harries
  
• 3.0
  Single-dose azithromycin for the treatment of cholera in adults.
  Recommended by Anthony Harries
  
• 6.4
  The survival benefits of AIDS treatment in the United States.
  Recommended by Anthony Harries, Paul Volberding
  
• 3.0
  Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
  Recommended by Anthony Harries
  
• 6.0
  Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study.
  Recommended by Anthony Harries
  
• 3.0
  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
  Recommended by Anthony Harries
  
• 4.9
  Spectrum of disease and relation to place of exposure among ill returned travelers.
  Recommended by Allen Cheng, Scott Halstead, Anthony Harries
  
• 3.0
  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
  Recommended by Anthony Harries
  
• 3.0
  Antiretroviral therapy in a thousand patients with AIDS in Haiti.
  Recommended by Anthony Harries
  
• 4.8
  Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study.
  Recommended by Anthony Harries, Mauricio L. Barreto
  
• 4.8
  Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
  Recommended by Anthony Harries, Conrad Hauser